Vedolizumab May Offer Hope for People with Colitis or Crohn’s Disease

One experimental drug that has been developed may be the answer for patients affected by inflammatory bowel disease that have been unresponsive to current medications. The drug is known as vedolizumab and is being developed to treat two forms of IBD – ulcerative colitis and Crohn’s Disease.

Both of these diseases occur in the digestive tract and can lead to chronic inflammation, abdominal cramps, diarrhea, and rectal bleeding. During new trials, researchers have discovered that vedolizumab had succeeded in cases where standard medications have been ineffective.

The drug was reported to be more effective for colitis than for Crohn’s. The drug may receive FDA approval for the treatment of colitis first. This is a potential new solution for the 2,000 patients that have either colitis or Crohn’s and have failed to see improvements from standard medications.

During a single trial, 47 percent of a group of 900 colitis patients given vedolizumab infusions reported a decrease in symptoms.

Our Blogs

Feast with Joy, Here’s to a Gutsy Holiday Season!

Back to BlogsThe holidays are upon us, and with them, that great holiday tradition - feasting! If you’re experiencing any digestive problems, visit the Beverly Hills Center for Digestive Health so we can identify and treat the issue and help you enjoy those holiday...

Warm Wishes for Your 2023 Thanksgiving, from Our Famiily to Yours!

Back to BlogsHappy Thanksgiving from the Beverly Hills Center for Digestive Health! On this day of gratitude, we're especially thankful for the trust and confidence our patients place in us. Dr. Davidson's extensive experience, from his medical degree at UCLA to his...

Fueling the Body, One Bite at a Time

Back to BlogsFood is fuel. With every bite, you are nourishing your body and helping it run. That is, as long as you have a healthy digestive system. If something in your system is going wrong, you may feel lethargic, bloated, or have any number of symptoms. If you...